Research Topics
| P A RingenSummaryAffiliation: University of Oslo Country: Norway Publications
| Collaborators
|
Detail Information
Publications
[Models and trends in psychiatry--should neurobiology form a common basis?]Petter Andreas Ringen
Klinikk for psykiatri Aker universitetssykehus 0320 Oslo
Tidsskr Nor Laegeforen 122:2024-7. 2002
Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorderP Andreas Ringen
KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, N 0424 Oslo, Norway
Schizophr Res 143:84-9. 2013..We investigated the relation between cannabis use, determined by its presence in urine, and neurocognitive functioning in schizophrenia controlling for the potential bias of premorbid functioning...
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive studyTrine V Lagerberg
Section for Psychosis Research, Oslo University Hospital, Bygg 49, Kirkevn, 166 N 0407 Oslo, Norway
BMC Psychiatry 10:9. 2010....
Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative studyJohn A Engh
Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
BMC Psychiatry 7:71. 2007..The relationship between the BCIS as a measure of cognitive insight and established methods for assessment of insight of illness was explored in both diagnostic groups...
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional studyP A Ringen
Institute of Psychiatry, University of Oslo, N 0317 Oslo, Norway, and Division of Psychiatry, Ulleval University Hospital, N 0407 Oslo, Norway
Acta Psychiatr Scand 117:133-8. 2008..Prevalence estimates of illicit drug use in psychotic disorders vary between studies, and only a few studies compared prevalence estimates with those in the general population...
Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorderP A Ringen
Institute of Psychiatry, Medical Faculty, University of Oslo, Oslo, Norway
Psychol Med 38:1241-9. 2008..The objective of the present study was to compare the prevalence of substance use in schizophrenia and bipolar disorder, and investigate possible differences in pattern and frequency of use...
[Medicine and psychiatry--in part and divided?]Petter Andreas Ringen
Avdeling for forskning og undervisning, Psykiatrisk divisjon, Ulleval universitetssykehus, 0407 Oslo
Tidsskr Nor Laegeforen 127:908-10. 2007
The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illnessP A Ringen
Institute of Psychiatry, University of Oslo, Oslo, Norway
Acta Psychiatr Scand 118:297-304. 2008..This study aims to investigate if the amount of illicit psychoactive drug use is related to symptom load or premorbid functioning across diagnosis in patients with severe mental illness...
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophreniaP A Ringen
Institute of Psychiatry, University of Oslo, N 0318 Oslo, Norway
Psychol Med 40:1337-47. 2010..The aim of this study was to investigate the association between cannabis use and neurocognition in bipolar disorder compared with schizophrenia in a naturalistic setting...
The effect of gender on emotion perception in schizophrenia and bipolar disorderA Vaskinn
Institute of Psychiatry, University of Oslo, Norway
Acta Psychiatr Scand 116:263-70. 2007..In healthy samples females perform better than males. This study compared emotion perception in schizophrenia and bipolar disorder and investigated the effects of gender...
Predictors of medication adherence in patients with schizophrenia and bipolar disorderH Jonsdottir
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Acta Psychiatr Scand 127:23-33. 2013..To investigate potential risk factors for medication non-adherence in patients with schizophrenia and bipolar disorder...
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditionsAstrid B Birkenaes
Section for Psychosis Research, Division of Psychiatry, Ulleval University Hospital and Institute of Psychiatry, Oslo, Norway
J Clin Psychopharmacol 28:132-7. 2008..We investigated how cardiometabolic risk factors were related to body mass during treatment with different APs under real-life conditions...
Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia?Anja Vaskinn
Institute of Psychiatry, University of Oslo, Oslo, Norway
J Int Neuropsychol Soc 14:279-88. 2008....
Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunctionCarmen Simonsen
Department of Psychiatry, Ulleval University Hospital, and Institute of Psychology, University of Oslo, Oslo, Norway
Bipolar Disord 10:245-55. 2008..The aim of this study was to examine whether patients with bipolar I and bipolar II disorder have different neurocognitive profiles...
